UK discovers counterfeit insulin pen needles

Britain’s medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them.

The counterfeit batch is Novofine Needles 31G (0.25mm x 6mm) with the lot number 08J02S, the Medicines and Healthcare Products Regulatory Agency (MHRA) said in a statement.

“The possible consequences of using these counterfeit needles could include adverse reactions; pain and discomfort; infection and difficulty in attaching the needle to the pen injection device,” it added.

The discovery is the latest example of fake medicines turning up in the supply chain and highlights the lucrative returns for criminals in passing off bogus treatments as genuine.

In recent years the MHRA has also found a number of counterfeit of batches of top-selling drugs, including Pfizer’s cholesterol fighter Lipitor and Sanofi-Aventis’ blood-thinner Plavix.

LONDON (Reuters)

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar   Joslin researchers find drugs are effective for diabetic macular edema in new trial   New superfoods could help key protein keep bodies healthy   Poor quality of life may affect teens’ diabetes management   Cancer drug protects against diabetes   Amino acid’s increase is suspected in diabetes   New Type 2 Diabetes Drug Onglyza Approved   Mail order pharmacy use safe for people with diabetes   Policy considerations pose options for leaders to reduce costly disparities in diabetes   Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery   Obesity-Linked Diabetes in Children Resists Treatment   Diabetes again linked to colon cancer risk